Subscribe


ASMI, Macquarie seal deal

THE Australian Self-Medication Industry has today formally launched its new partnership with Sydney’s Macquarie University (PD 09 Aug), which “will produce for the very first time independent, evidence-based research into the current and future impact of self care and self-medication on public health in Australia”. The research program, which will be conducted in three phases over the next year, will determine the value of the consumer healthcare industry in the Australian economic environment, develop insights into consumer attitudes and behaviour towards self care, and “the value of self care in contributing to a sustainable healthcare system in the future”. Pictured above celebrating the collaboration are, from left: Professor Mark Gabbott, Pro Vice Chancellor International Macquarie University; Sakkie Pretorius, Deputy Vice Chancellor Macquarie University; Ralf Dahmen, ASMI vice president and md Omega Pharma; and Deon Schoombie, ASMI executive director. THE Australian Self-Medication Industry has today formally launched its new partnership with Sydney’s Macquarie University (PD 09 Aug), which “will produce for the very first time independent, evidence-based research into the current and future impact of self care and self-medication on public health in Australia”. The research program, which will be conducted in three phases over the next year, will determine the value of the consumer healthcare industry in the Australian economic environment, develop insights into consumer attitudes and behaviour towards self care, and “the value of self care in contributing to a sustainable healthcare system in the future”.
Pictured above celebrating the collaboration are, from left: Professor Mark Gabbott, Pro Vice Chancellor International Macquarie University; Sakkie Pretorius, Deputy Vice Chancellor Macquarie University; Ralf Dahmen, ASMI vice president and md Omega Pharma; and Deon Schoombie, ASMI executive director.